查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513887

胰島素輸送系統的全球市場

Insulin Delivery Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 272 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球胰島素輸送系統市場預計將達到 168 億美元

2023年全球胰島素輸送系統市場預計為134億美元，預計到2030年將達到168億美元，2023-2030年分析期間複合年成長率為3.3%。注射器是本報告分析的細分市場之一，預計複合年成長率為 3.4%，到分析期結束時將達到 70 億美元。分析期內，鋼筆細分市場的複合年成長率預計為 4.3%。

美國市場預估36億美元，中國預估複合年增率5.8%

預計 2023 年美國胰島素輸送系統市場規模將達 36 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達34億美元，2023-2030年分析期間複合年成長率為5.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 0.6% 和 4.0%。在歐洲，德國的複合年成長率預計為 1.4%。

胰島素輸送系統 - 主要趨勢和促進因素

胰島素輸送系統是糖尿病治療的重要組成部分，糖尿病是一種影響全世界數百萬人的慢性疾病。這些系統旨在以受控且有效的方式輸送胰島素（一種調節血糖值所需的荷爾蒙）。胰島素輸送系統有許多不同類型，包括注射器、胰島素筆、胰島素幫浦和吸入胰島素等新方法。這些系統在便利性、準確性和使用者體驗方面都列出了不同的優勢。例如，胰島素筆是許多患者的熱門選擇，因為它們是預填充且易於攜帶的。胰島素幫浦對第 1 型糖尿病患者特別有益，因為它們可以持續分泌接近人體自然胰島素分泌的胰島素。隨著醫療技術的進步和對患者需求的深入了解，情況正在不斷發展。

科技創新是胰島素輸送系統進步的主要驅動力。現代胰島素幫浦具有先進的功能，例如連續血糖監測 (CGM) 整合、自動胰島素劑量 (AID) 和智慧型手機連接。這些進步使得糖尿病管理更加精確和個人化，降低低血糖風險並改善整體血糖控制。此外，可以追蹤劑量並提供提醒的智慧胰島素筆的開發有助於解決藥物依從性和劑量準確性問題。吸入式胰島素的採用為注射提供了一種非侵入性的替代方案，對不喜歡針頭的患者很有吸引力。此外，研究正在進展到閉合迴路系統，也稱為人工胰臟系統，其目標是創建全自動胰島素輸送解決方案，同時最大限度地減少患者干涉。這些技術創新不僅改善了糖尿病患者的生活品質，也為糖尿病治療樹立了新標準。

胰島素輸送系統市場的成長受到多種因素的推動，例如糖尿病盛行率的增加、技術的進步以及糖尿病管理意識的提高。由於肥胖和久坐的生活方式等因素，糖尿病（尤其是第 2 型糖尿病）盛行率不斷上升，大大擴大了對高效且易於使用的胰島素輸送解決方案的需求。技術的進步使這些系統更容易使用和有效，吸引了更廣泛的患者群體。行動應用程式和雲端基礎的資料管理等數位健康技術的整合正在增強患者的參與度和對治療通訊協定的遵守。消費者的行為也在發生變化，強調便利性和侵入性較小的選擇，推動了智慧筆和吸入胰島素等創新輸送方法的採用。此外，旨在改善糖尿病治療基礎設施的政府支持政策和舉措正在推動市場成長。競爭格局的特點是高科技公司和醫療保健提供者之間的合作，進一步加速創新和市場滲透。總體而言，在人口趨勢、技術進步和不斷變化的患者偏好的共同推動下，胰島素輸送系統市場預計將顯著擴大。

調查企業舉例（共32家）

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG

目錄

第1章調查方法

第2章執行概述

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-6283

Global Insulin Delivery Systems Market to Reach US$16.8 Billion by 2030

The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Syringes, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$7.0 Billion by the end of the analysis period. Growth in the Pens segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 5.8% CAGR

The Insulin Delivery Systems market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Insulin Delivery Systems - Key Trends and Drivers

Insulin delivery systems are a critical component in the management of diabetes, a chronic condition affecting millions of people worldwide. These systems are designed to administer insulin, a hormone necessary for regulating blood glucose levels, in a controlled and efficient manner. There are various types of insulin delivery systems, including syringes, insulin pens, insulin pumps, and newer methods like inhalable insulin. Each of these systems offers different advantages in terms of convenience, precision, and user experience. Insulin pens, for example, are prefilled and easy to carry, making them a popular choice for many patients. Insulin pumps provide continuous insulin delivery, closely mimicking the body’s natural insulin release, which is particularly beneficial for individuals with type 1 diabetes. The landscape of insulin delivery systems is continuously evolving, driven by advancements in medical technology and a deeper understanding of patient needs.

Technological innovation has been a significant driver in the advancement of insulin delivery systems. Modern insulin pumps are now equipped with advanced features such as continuous glucose monitoring (CGM) integration, automated insulin delivery (AID), and smartphone connectivity. These advancements allow for more precise and personalized diabetes management, reducing the risk of hypoglycemia and improving overall glycemic control. Additionally, the development of smart insulin pens, which can track doses and provide reminders, is helping to address issues related to adherence and dosing accuracy. The introduction of inhalable insulin offers a non-invasive alternative to injections, appealing to patients who are needle-averse. Furthermore, research into closed-loop systems, also known as artificial pancreas systems, is ongoing, with the goal of creating fully automated insulin delivery solutions that require minimal patient intervention. These innovations are not only improving the quality of life for diabetes patients but are also setting new standards in diabetes care.

The growth in the insulin delivery systems market is driven by several factors, including the increasing prevalence of diabetes, technological advancements, and a growing awareness of diabetes management. The rising incidence of diabetes particularly type 2 diabetes, due to factors such as obesity and sedentary lifestyles, has significantly expanded the demand for efficient and user-friendly insulin delivery solutions. Technological advancements have made these systems more accessible and effective, attracting a broader patient base. The integration of digital health technologies, such as mobile apps and cloud-based data management, is enhancing patient engagement and adherence to treatment protocols. Consumer behavior is also shifting, with a greater emphasis on convenience and minimally invasive options, driving the adoption of innovative delivery methods like smart pens and inhalable insulin. Additionally, supportive government policies and initiatives aimed at improving diabetes care infrastructure are facilitating market growth. The competitive landscape is marked by collaborations between tech companies and healthcare providers, further accelerating innovation and market penetration. Overall, the insulin delivery systems market is poised for significant expansion, propelled by a combination of demographic trends, technological progress, and evolving patient preferences.

Select Competitors (Total 32 Featured) -

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Insulin Delivery Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Throws the Spotlight on Insulin Delivery Systems
    • Technological Advancements Propel Growth in Smart Insulin Delivery Devices
    • Increasing Adoption of Continuous Glucose Monitoring (CGM) Systems Expands Addressable Market Opportunity
    • Integration of Digital Health Technologies Strengthens Business Case for Advanced Insulin Delivery Solutions
    • Development of Automated Insulin Delivery (AID) Systems Boost Innovation
    • Non-Invasive Delivery Methods, Such as Inhalable Insulin, Drive Adoption among Needle-Averse Patients
    • Enhanced Smartphone Connectivity and Mobile App Integration Spurs Growth in User Engagement
    • Personalized Diabetes Management Generates Demand for Customized Insulin Delivery Solutions
    • Research into Closed-Loop Systems and Artificial Pancreas Technology Throws the Spotlight on Future Trends
    • Increased Focus on Minimally Invasive Options Expands Addressable Market Opportunity
    • Consumer Shift towards Convenience and Ease of Use Drives Adoption of Innovative Insulin Delivery Methods
    • Enhanced Data Management and Cloud-Based Solutions Generates Demand for Integrated Insulin Delivery Systems
    • Rising Incidence of Type 2 Diabetes among Younger Populations Influences Market Dynamics
    • Improving Quality of Life for Diabetes Patients Sustains Growth in Advanced Insulin Delivery Technologies
    • Evolution of Smart Insulin Pens and Dose Tracking Technologies Strengthens Business Case for Precision Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Insulin Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pen needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030

IV. COMPETITION